David Jaques
@davjaques.bsky.social
Reposted by David Jaques
Going to add this to my lecture slides.
August 26, 2025 at 6:05 PM
Going to add this to my lecture slides.
Reposted by David Jaques
#NephMadness 2025 Commentary by @hswapnil.medsky.social on the Resistant Hypertension region:
Renal Denervation in Hypertension: Fad or Fixture?
bit.ly/NM25Hiremath
Renal Denervation in Hypertension: Fad or Fixture?
bit.ly/NM25Hiremath
#NephMadness 2025: Renal Denervation in Hypertension: Fad or Fixture?
Submit your picks! | @NephMadness | @nephmadness.bsky.social | NephMadness 2025 Swapnil Hiremath Swapnil Hiremath is a Professor at the University of Ottawa and an Associate Scientist at the Otta…
bit.ly
March 19, 2025 at 2:48 PM
#NephMadness 2025 Commentary by @hswapnil.medsky.social on the Resistant Hypertension region:
Renal Denervation in Hypertension: Fad or Fixture?
bit.ly/NM25Hiremath
Renal Denervation in Hypertension: Fad or Fixture?
bit.ly/NM25Hiremath
Reposted by David Jaques
Very low SBP targets & the boom-and-bust cycle of benefit & adverse kidney events
doi.org/10.1093/ndt/...
A review of the long-term mortality & kidney failure outcomes of participants in the SPRINT trial & their implication for the treatment of hypertension, management of CKD & research agenda
doi.org/10.1093/ndt/...
A review of the long-term mortality & kidney failure outcomes of participants in the SPRINT trial & their implication for the treatment of hypertension, management of CKD & research agenda
Very low SBP targets and the boom-and-bust cycle of benefit and adverse kidney events
Beatriz Fernandez-Fernandez, Jose M Valdivielso, Shanmugakumar Chinnappa, Pantelis Sarafidis, Alberto Ortiz, on behalf of the EuReCa-M working group of the
doi.org
March 10, 2025 at 12:08 PM
Very low SBP targets & the boom-and-bust cycle of benefit & adverse kidney events
doi.org/10.1093/ndt/...
A review of the long-term mortality & kidney failure outcomes of participants in the SPRINT trial & their implication for the treatment of hypertension, management of CKD & research agenda
doi.org/10.1093/ndt/...
A review of the long-term mortality & kidney failure outcomes of participants in the SPRINT trial & their implication for the treatment of hypertension, management of CKD & research agenda